Global and United States COPD Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 1014966 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Bronchodilators
        1.2.3 Inhaled Corticosteroids
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global COPD Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Adult
        1.3.3 Child
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global COPD Therapeutics Market Perspective (2016-2027)
    2.2 COPD Therapeutics Growth Trends by Regions
        2.2.1 COPD Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 COPD Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 COPD Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 COPD Therapeutics Industry Dynamic
        2.3.1 COPD Therapeutics Market Trends
        2.3.2 COPD Therapeutics Market Drivers
        2.3.3 COPD Therapeutics Market Challenges
        2.3.4 COPD Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top COPD Therapeutics Players by Revenue
        3.1.1 Global Top COPD Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by COPD Therapeutics Revenue
    3.4 Global COPD Therapeutics Market Concentration Ratio
        3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2020
    3.5 COPD Therapeutics Key Players Head office and Area Served
    3.6 Key Players COPD Therapeutics Product Solution and Service
    3.7 Date of Enter into COPD Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Therapeutics Breakdown Data by Type
    4.1 Global COPD Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global COPD Therapeutics Forecasted Market Size by Type (2022-2027)

5 COPD Therapeutics Breakdown Data by Application
    5.1 Global COPD Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global COPD Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America COPD Therapeutics Market Size (2016-2027)
    6.2 North America COPD Therapeutics Market Size by Type
        6.2.1 North America COPD Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America COPD Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America COPD Therapeutics Market Size by Type (2016-2027)
    6.3 North America COPD Therapeutics Market Size by Application
        6.3.1 North America COPD Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America COPD Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America COPD Therapeutics Market Size by Application (2016-2027)
    6.4 North America COPD Therapeutics Market Size by Country
        6.4.1 North America COPD Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America COPD Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe COPD Therapeutics Market Size (2016-2027)
    7.2 Europe COPD Therapeutics Market Size by Type
        7.2.1 Europe COPD Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe COPD Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe COPD Therapeutics Market Size by Type (2016-2027)
    7.3 Europe COPD Therapeutics Market Size by Application
        7.3.1 Europe COPD Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe COPD Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe COPD Therapeutics Market Size by Application (2016-2027)
    7.4 Europe COPD Therapeutics Market Size by Country
        7.4.1 Europe COPD Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe COPD Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific COPD Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific COPD Therapeutics Market Size by Type
        8.2.1 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific COPD Therapeutics Market Size by Application
        8.3.1 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific COPD Therapeutics Market Size by Region
        8.4.1 Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America COPD Therapeutics Market Size (2016-2027)
    9.2 Latin America COPD Therapeutics Market Size by Type
        9.2.1 Latin America COPD Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America COPD Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America COPD Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America COPD Therapeutics Market Size by Application
        9.3.1 Latin America COPD Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America COPD Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America COPD Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America COPD Therapeutics Market Size by Country
        9.4.1 Latin America COPD Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America COPD Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa COPD Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa COPD Therapeutics Market Size by Type
        10.2.1 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa COPD Therapeutics Market Size by Application
        10.3.1 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa COPD Therapeutics Market Size by Country
        10.4.1 Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
        11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca COPD Therapeutics Introduction
        11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2016-2021)
        11.2.5 AstraZeneca Recent Development
    11.3 Theravance Biopharma
        11.3.1 Theravance Biopharma Company Details
        11.3.2 Theravance Biopharma Business Overview
        11.3.3 Theravance Biopharma COPD Therapeutics Introduction
        11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021)
        11.3.5 Theravance Biopharma Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Mylan Business Overview
        11.4.3 Mylan COPD Therapeutics Introduction
        11.4.4 Mylan Revenue in COPD Therapeutics Business (2016-2021)
        11.4.5 Mylan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Bronchodilators
    Table 3. Key Players of Inhaled Corticosteroids
    Table 4. Key Players of Other
    Table 5. Global COPD Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global COPD Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global COPD Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global COPD Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global COPD Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global COPD Therapeutics Market Share by Regions (2022-2027)
    Table 11. COPD Therapeutics Market Trends
    Table 12. COPD Therapeutics Market Drivers
    Table 13. COPD Therapeutics Market Challenges
    Table 14. COPD Therapeutics Market Restraints
    Table 15. Global COPD Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global COPD Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020)
    Table 18. Ranking of Global Top COPD Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players COPD Therapeutics Product Solution and Service
    Table 22. Date of Enter into COPD Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global COPD Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global COPD Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global COPD Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global COPD Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. GlaxoSmithKline Company Details
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline COPD Therapeutics Product
    Table 65. GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Development
    Table 67. AstraZeneca Company Details
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca COPD Therapeutics Product
    Table 70. AstraZeneca Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. AstraZeneca Recent Development
    Table 72. Theravance Biopharma Company Details
    Table 73. Theravance Biopharma Business Overview
    Table 74. Theravance Biopharma COPD Therapeutics Product
    Table 75. Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Theravance Biopharma Recent Development
    Table 77. Mylan Company Details
    Table 78. Mylan Business Overview
    Table 79. Mylan COPD Therapeutics Product
    Table 80. Mylan Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Mylan Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COPD Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Bronchodilators Features
    Figure 3. Inhaled Corticosteroids Features
    Figure 4. Other Features
    Figure 5. Global COPD Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Adult Case Studies
    Figure 7. Child Case Studies
    Figure 8. COPD Therapeutics Report Years Considered
    Figure 9. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global COPD Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global COPD Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 12. Global COPD Therapeutics Market Share by Regions (2022-2027)
    Figure 13. Global COPD Therapeutics Market Share by Players in 2020
    Figure 14. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2020
    Figure 16. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 17. Global COPD Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 18. North America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America COPD Therapeutics Market Share by Type (2016-2027)
    Figure 20. North America COPD Therapeutics Market Share by Application (2016-2027)
    Figure 21. North America COPD Therapeutics Market Share by Country (2016-2027)
    Figure 22. United States COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe COPD Therapeutics Market Share by Type (2016-2027)
    Figure 26. Europe COPD Therapeutics Market Share by Application (2016-2027)
    Figure 27. Europe COPD Therapeutics Market Share by Country (2016-2027)
    Figure 28. Germany COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific COPD Therapeutics Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific COPD Therapeutics Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific COPD Therapeutics Market Share by Region (2016-2027)
    Figure 38. China COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America COPD Therapeutics Market Share by Type (2016-2027)
    Figure 46. Latin America COPD Therapeutics Market Share by Application (2016-2027)
    Figure 47. Latin America COPD Therapeutics Market Share by Country (2016-2027)
    Figure 48. Mexico COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa COPD Therapeutics Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa COPD Therapeutics Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa COPD Therapeutics Market Share by Country (2016-2027)
    Figure 54. Turkey COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
    Figure 58. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
    Figure 59. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
    Figure 60. Mylan Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
Frequently Asked Questions
COPD Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
COPD Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
COPD Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hemangioma

Global Hemangioma Scope and Market Size
Hemangioma market is segmented by company,  ... Read More

Nonyl Acetate

Nonyl Acetate market is segmented by region (country), players, by Type, and by Application. Play ... Read More